; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (160) Trifloxystrobin and tebuconazole formulations Heading 9902.09.53 is amended— (A) by amending the article description to read as follows: Product mixtures containing methyl (E)-methoxyimino-{(E)-2-[1-(α,α,α-trifluoro-m-tolyl) ethylideneaminooxy]-o-tolyl}acetate (Trifloxystrobin) (CAS No. 141517–21–7) and (RS)-1-p-chlorophenyl-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl) pentan-3-ol (Tebuconazole) (CAS No. 107534–96–3) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (161) Fluopyram + pyrimethanil formulations Heading 9902.09.54 is amended— (A) by amending the article description to read as follows: Product mixtures containing N-[2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethyl]-2-(trifluoromethyl) benzamide (Fluopyram) (CAS No. 658066–35–4) and 4,6-dimethyl-N-phenyl-2-pyrimidinamine (Pyrimethanil) (CAS No. 53112–28–0) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (162) Fluopyram and trifloxystrobin formulations Heading 9902.09.55 is amended— (A) by amending the article description to read as follows: Product mixtures containing N-[2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethyl]-2-(trifluoromethyl) benzamide (Fluopyram) (CAS No. 658066–35–4) and methyl (E)-methoxyimino-{(E)-2-[1-(α,α,α-trifluoro-m-tolyl) ethylideneaminooxy]-o-tolyl} acetate (Trifloxystrobin) (CAS No. 141517–21–7) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (163) Trifloxystrobin formulations Heading 9902.09.57 is amended— (A) by amending the article description to read as follows: Product mixtures containing methyl (2E)-(methoxyimino)[2-({[(E)-{1-[3-(trifluoromethyl) phenyl] ethylidene}amino]oxy}methyl)phenyl]acetate (Trifloxystrobin) (CAS No. 141517–21–7) (provided for in subheading 3808.92.15)